Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heat Biologics, Inc. - Common Stock (NY: HTBX )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, May 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 2.250 (1)
Ask (Size) 2.700 (1)
Prev. Close 2.380
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 4,331,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Heat Biologics' Subsidiary Outlines Development of New Commercial/Biodefense Biomanufacturing Facility
Via Benzinga
66 Biggest Movers From Yesterday
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement. Forge Global... 
Via Benzinga

Performance

More News

Read More
Heat Biologics' Merger Partner Elusys Finalizes HHS Contract For Its Anthrax Treatment
Via Benzinga
Heat Biologics Is Starting To Run Away From Support Toward Resistance
Via Benzinga
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
Via Benzinga
Heat Biologics To Bolster Presence In Biodefense Space With Elusys Acquisition
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
64 Biggest Movers From Friday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Heat Biologics Surges On Patent Filing
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
66 Biggest Movers From Yesterday
Via Benzinga
Heat Biologics' Lead Candidate Shows Overall Survival Benefit In Lung Cancer Study
Via Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021
From Heat Biologics, Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.